Teruya-Feldstein, Julie
Histowiz,
United States
2025 Rank: 71035
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Pathology
Rank in SubField 1: 1984 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 71035 | 76956 |
| Total Cites | 25380 | 27406 |
| H-index | 80 | 87 |
| Hm-index | 19 | 19 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 73 | 74 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 831 | 910 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 1662 | 1787 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 22872 | 24332 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.13 |
| Self-Citation Percentage |
7.39%
|
|
Teruya-Feldstein, Julie
Histowiz,
United States
2024 Rank: 68411
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Pathology
Rank in SubField 1: 1951 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 68411 | 74029 |
| Total Cites | 24162 | 26115 |
| H-index | 78 | 85 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 70 | 71 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 807 | 885 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 1597 | 1722 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 21774 | 23177 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.13 |
| Self-Citation Percentage |
7.48%
|
|
Teruya-Feldstein, Julie
Icahn School of Medicine at Mount Sinai,
United States
2023 Rank: 66147
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Pathology
Rank in SubField 1: 1924 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 66147 | 71058 |
| Total Cites | 22718 | 24593 |
| H-index | 75 | 83 |
| Hm-index | 18 | 18 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 69 | 70 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 787 | 862 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 1538 | 1660 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 20458 | 21802 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.13 |
| Self-Citation Percentage |
7.62%
|
|
Teruya-Feldstein, Julie
Memorial Sloan-Kettering Cancer Center,
United States
2022 Rank: 66280
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Pathology
Rank in SubField 1: 1959 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 66280 | 72487 |
| Total Cites | 20209 | 21821 |
| H-index | 71 | 76 |
| Hm-index | 17 | 17 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 66 | 67 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 760 | 836 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 1448 | 1571 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 18216 | 19366 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.13 |
| Self-Citation Percentage |
7.39%
|
|
Teruya-Feldstein, Julie
Icahn School of Medicine at Mount Sinai,
United States
2021 Rank: 66489
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Pathology
Rank in SubField 1: 1970 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 66489 | 73297 |
| Total Cites | 19278 | 20813 |
| H-index | 69 | 73 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 62 | 63 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 738 | 811 |
| Number of Single+First+Last Authored Papers | 45 | 45 |
| Total Cites to Single+First+Last Authored Papers | 1413 | 1533 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 17391 | 18481 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.13 |
| Self-Citation Percentage |
7.38%
|
|
Teruya-Feldstein, Julie
Icahn School of Medicine at Mount Sinai,
United States
2020 Rank: 60809
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1820 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 60809 | 66202 |
| Total Cites | 18759 | 20358 |
| H-index | 68 | 74 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 60 | 61 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 718 | 782 |
| Number of Single+First+Last Authored Papers | 42 | 42 |
| Total Cites to Single+First+Last Authored Papers | 1327 | 1435 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 16856 | 17991 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.13 |
| Self-Citation Percentage |
7.85%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.